Tag:

Eye Conditions

STOCK MARKET
Amgen wins battle for Horizon Therapeutics, bolstering its rare-disease portfolio

by user December 12, 2022

by user December 12, 2022

[ad_1] Amgen Inc. said Monday that it’s acquiring Dublin-based Horizon Therapeutics in a roughly $28…

Read more

0 Facebook Twitter Pinterest Email
STOCK MARKET
Roche’s vision-loss drug Vabysmo gets EU nod

by user September 19, 2022

by user September 19, 2022

[ad_1] Roche Holding AG said Monday that its vision-loss treatment Vabysmo has been approved in…

Read more

0 Facebook Twitter Pinterest Email

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy